Hagan serves as Chief Commercial Officer at ModifyHealth and has a history of commercializing innovative products and services that have dramatic impact on patient care. Prior to ModifyHealth, Hagan helped launch EndoChoice, a developer of innovative healthcare products and services for the GI space. While at EndoChoice, Hagan served in multiple sales and marketing leadership roles including Global Marketing Leader for Imaging & Technology Enabled Services as as well as Senior Director of Marketing. EndoChoice grew from a startup in 2008 to public offering in 2015 (NYSE: GI) and final sale to Boston Scientific in 2016 (NYSE: BSX). During Hagan’s time at Boston Scientific, he served in multiple roles including Group Manager of Pathology and Marketing Channel Manager for the GI Ambulatory Surgery Center Division.